3M Expands Surgical Portfolio with PREVENA RESTOR AXIO•FORM™ Incision Management System, a New Way to Address Challenges ...
October 28 2020 - 9:00AM
Business Wire
The PREVENA RESTOR™ Therapy portfolio optimizes post-operative
care by delivering negative pressure therapy to the incision and
surrounding soft tissue to enhance recovery
3M today is announcing the availability of PREVENA RESTOR
AXIO•FORM™ Incision Management System, designed to manage
post-operative incisions, as well as the surrounding soft tissue
envelope, following the orthopedic surgical repair of lower
extremity fractures. PREVENA RESTOR AXIO•FORM™ helps stabilize the
incision & surrounding soft tissue, reduce edema, and help
enhance post-operative recovery. This is the third offering in the
PREVENA RESTOR™ Therapy portfolio, launched in 2019, to optimize
post-surgical care and expand the company’s specialty surgical
offerings.
“Patients recovering from lower extremity fractures often
experience complications which can potentially compromise the
healing process, leading to delayed rehabilitation and poor
functional outcomes,” said Dr. Brett D. Crist, MD, FAAOS, FACS,
FAOA, Director of Orthopaedic Surgery, University of Missouri
School of Medicine, who participated in the pre-market pilot. “The
PREVENA RESTOR AXIO•FORM™ System provides a unique solution for
post-surgical incision and soft tissue envelope management for the
lower extremity – which can be one of the most complex and
challenging anatomical areas. The expanded coverage and precision
design lend themselves to better conformity on the surgical site,
providing us confidence for our patients’ recovery.”
The PREVENA RESTOR AXIO•FORM™ System encompasses the same proven
technology as the PREVENA™ Incision Management System, with added
benefits including:
- Extended therapy time: up to 14 days (dressing change required
after seven days);
- Expanded coverage area: dressing seamlessly conforms to the
patient;
- Precision design: larger dressing delivers therapy to incision
and surrounding soft tissue envelope;
- Mechanically stabilize the incision and surrounding soft
tissue;
- Easy to apply, form-fitting PEEL & PLACE™ dressing
“Not all surgical incisions are the same size, and orthopedic
fracture repairs can be complex, which is why we offer clinicians a
variety of products to accommodate their individual patient’s
needs,” said Ronald Silverman, MD, FACS, Chief Medical Officer, 3M.
“Given the current pandemic, it is even more critical to minimize
the length of hospital stays for patients and, once they return
home, lessen the number of in-person visits during recovery.
PREVENA RESTOR AXIO•FORM™ System aims to get patients home quickly
and safely post-surgery, which is a priority now more than
ever.”
The PREVENA RESTOR AXIO•FORM™ System was made commercially
available in August 2020. Information on the PREVENA RESTOR
AXIO•FORM™ System is available on the American Orthopedic Foot
& Ankle Society (AOFAS) and Orthopedic Trauma Association (OTA)
annual conference websites.
“Our team at 3M is pleased that, with the introduction of the
PREVENA RESTOR AXIO•FORM™ System, we are further advancing how
orthopedic surgeons care for patients recovering from lower
extremity fractures by rethinking recovery and reimagining the
traditional applications of negative pressure—all backed by the
undisputed outcomes of PREVENA™ Therapy,” said Mark Colin,
Vice-President, 3M Medical Solutions Division.
About PREVENA™ Therapy & PREVENA RESTOR AXIO•FORM™
Incision Management System
The PREVENA™ Therapy System, launched in 2010, is the first
disposable negative pressure system designed specifically for the
management of closed surgical incisions. PREVENA™ Therapy Systems
removes fluid away from the surgical incision via the application
of -125mmHg continuous negative pressure.
The PREVENA RESTOR™ Incision Management System is intended to
manage the environment of surgical incisions that continue to drain
following sutured or stapled closure by maintaining a closed
environment and removing exudates via the application of negative
pressure wound therapy.
Please refer to the PREVENA RESTOR AXIO•FORM™ System
Instructions For Use for important safety information.
About 3M
At 3M, we apply science in collaborative ways to improve lives
daily. With $33 billion in sales, our 93,000 employees connect with
customers all around the world. Learn more about 3M’s creative
solutions to the world’s problems at www.3M.com or on Twitter @3M
or @3MNews.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201028005127/en/
Emilie Petersen epetersen2@mmm.com Lindsey Bailys
Lindsey.Bailys@gcihealth.com
3M (NYSE:MMM)
Historical Stock Chart
From Mar 2024 to Apr 2024
3M (NYSE:MMM)
Historical Stock Chart
From Apr 2023 to Apr 2024